Invest in the Future of Critical Care with Eliaz Therapeutics

“An investment in ETI is a no-brainer for me. For someone who cares deeply about the health and wellbeing of humanity, seeing this powerful new technology come to market that could save millions of people’s lives by implementing a non-toxic approach in healthcare is exactly what we need at this time, and there's no one better to bring it to the world than Dr. Isaac Eliaz. This investment opportunity will change lives and give a powerful financial opportunity of growth, and I'm very happy to be a part of it.”

“As someone who suffers from several autoimmune diseases that can lead to organ failure due to constant inflammation, this is groundbreaking. So happy to be able to contribute to this medical breakthrough!!”

“I've been an ICU & ER RN for 30 years and have witnessed so many treatments for sepsis including medications that have actually caused severe harm and death to patients and subsequently taken off the market. This device is of great interest to me and being a part of the ground floor investing in the innovation is exciting.”

“As a combat veteran and investor focused on meaningful innovation, I was drawn to Eliaz Therapeutics' mission to address the global crisis of sepsis with a novel, science-backed approach. The XGal-3® platform has the potential to save lives and transform care. I believe in backing bold teams solving critical problems—and this is one of them.”

“I chose to invest in your company because there must be a better solution for detecting and treating sepsis. I was hospitalized with a sudden onset of sepsis. I had no idea how life-threatening sepsis could be—I assumed it only impacted older individuals or those already hospitalized. What you are building has the power to save lives and prevent needless deaths from something that can strike anyone, of any age, at any time. I’m honored to support it!”